Free preview
MD Pharmacology NMC syllabus ~5 min read Recent advances last updated on 2026-06-19

Membrane Transporters & Drug Response

ABC & SLC transporters in pharmacokinetics, drug targeting, resistance and adverse drug responses

Past RGUHS · 7 RGUHSSep '25 RGUHSNov '22 RGUHSMay '22 RGUHSMay '19 RGUHSNov '18 RGUHSOct '10 RGUHSMay '10

Introduction & pharmacological importance

  • Membrane transporters — integral membrane proteins that control influx of nutrients/ions and efflux of waste, toxins, drugs and other xenobiotics; ~2000 genes (~7% of the human genome) encode transporters or transporter-related proteins.
  • Two superfamilies — pharmacologically the field centres on ABC (ATP-binding cassette) primary-active efflux pumps and SLC (solute carrier) facilitative / secondary-active carriers.
  • Four pharmacological dimensions — (1) Pharmacokinetics — selective absorption/elimination in gut, liver and kidney + protective barriers; (2) Pharmacodynamics — transporters as drug targets (SERT, SGLT2); (3) Drug resistance — efflux/influx changes in cancer, HIV, epilepsy; (4) Adverse responses — control cellular drug exposure → toxicity and drug–drug interactions (DDIs).
  • Membrane basis — a ~100 Å phospholipid + cholesterol bilayer (fluid-mosaic) of high electrical resistance and relative impermeability; aqueous pores and paracellular spaces allow some small-molecule passage.
Continue reading

Membrane Transporters

PharmaNotes Pro · LAQ

Sign in with your Google account. If you're already subscribed, the chapter unlocks immediately — otherwise, pick Monthly or Annual on the next step.